Steroid-Resistant Uveitis at a Glance
If you were told you have uveitis but steroid drops, pills, or injections are not calming it down, that does not automatically mean the medicine failed. Sometimes it means the diagnosis deserves a second look. Uveitis is a group of inflammatory conditions inside the eye, and steroids are the most common first treatment for it1. When the inflammation keeps coming back or never settles, doctors are taught to step back and ask whether something else is imitating uveitis. This page explains why that happens and how a second opinion can help, without telling you what your own diagnosis is.
A poor response can have several honest explanations. The dose or delivery may have been too low for your type of inflammation. The uveitis may need a stronger medicine that steroids alone cannot replace. Or the problem may not be ordinary inflammation at all. Conditions that mimic uveitis but come from a different cause are called masquerade syndromes, and they include cancers such as intraocular lymphoma, leukemia, and other tumors2. Sorting these apart is exactly the kind of question a fresh, expert set of eyes is meant to answer.
You do not need to panic, and you do not need to abandon your current doctor. A reasonable next step is to ask whether the diagnosis has been reconsidered and whether a uveitis or retina specialist should weigh in. Untreated uveitis can lead to vision loss, so ongoing or worsening symptoms should be seen promptly rather than watched at home1. The rest of this page walks through the reasons a second look is worthwhile and how to make that visit count.
Why Some 'Uveitis' Does Not Settle With Steroids
A masquerade syndrome is a condition that produces cells and haze inside the eye that look like inflammation but come from a different cause. Masquerade syndromes are a group of eye diseases that mimic chronic inflammation inside the eye, and they include cancers such as intraocular lymphoma, leukemia, and other tumors2. Because steroids treat inflammation, they often do little for a masquerade, which is one reason a stubborn 'flare' can be a clue rather than a failure.
Some infections settle in the eye and mimic inflammatory uveitis. Specialists are taught to always consider masqueraders such as syphilis and sarcoidosis in eye inflammation, no matter where in the eye it is3. This is why a careful workup often includes blood tests and imaging, not just a look inside the eye. Getting the label right changes the treatment completely, since an infection needs the right anti-infective rather than more steroid.
In older adults, a rare eye cancer can hide behind a uveitis label. In people over 50 with vitreous inflammation that keeps returning, a cancer called primary vitreoretinal lymphoma is an important masquerade to rule out4. Almost all of these lymphomas are a type of non-Hodgkin B-cell lymphoma, and the condition is closely linked to lymphoma of the brain and spinal cord5. That link is the reason a correct, timely diagnosis matters so much, and it is a large part of why specialists take a steroid-resistant older patient seriously.
Sometimes the eye inflammation is a side effect of a drug taken for another reason. Certain medicines, including rifabutin and some cancer immunotherapy drugs known as immune checkpoint inhibitors, can themselves cause uveitis6. Drug-induced uveitis often improves once the responsible medicine is identified and stopped6. A second opinion is a good moment to review every medicine you take, because a drug cause is easy to miss when attention is on the eye alone.
Signs That Favor a Second Look Versus a Genuine Flare
No single sign settles the question, and only your own doctors can examine your eye. The contrast below shows patterns that specialists weigh, not a diagnosis you can make at home.
| Feature | More typical of ordinary uveitis | Reason to reconsider the label |
|---|---|---|
| Response to steroids | Inflammation eases within days to weeks | Little or no lasting response despite good treatment |
| Age at onset | Any age, often younger adults | New vitreous inflammation after age 50 |
| Pattern over time | Clear flares that settle, then return | Persistent haze that never fully clears |
| Whole-body clues | Known inflammatory or autoimmune condition | Recent new medicine, infection risk, or cancer history |
Age and the shape of the illness over time are among the strongest clues a specialist uses. A patient 50 or older with steroid-resistant inflammation, ongoing vitritis, few changes in the retina, and fairly preserved vision is the classic picture that prompts a lymphoma workup4. None of these features alone proves anything, which is exactly why the whole pattern, read by someone who sees many uveitis cases, matters more than any one detail.
Reports of patients first treated as uveitis, then found to have a masquerade, are a recurring theme in the eye literature. Case series describe patients treated for uveitis whose true diagnosis was a masquerade, showing that a poor response to anti-inflammatory treatment is a recognized reason to reconsider2. The lesson is not that first diagnoses are usually wrong, but that a stubborn case earns a fresh, thorough review.
Is a Second Opinion Right for You?
A second opinion is most useful when the picture is not adding up. Referral to a uveitis specialist is recommended when the diagnosis is unclear or when treatment has not produced the expected result3. Reasonable prompts include inflammation that has not responded after a fair trial, a diagnosis that was never fully explained, repeated flares, or simply wanting confidence before committing to long-term immune-suppressing medicine. Wanting to understand your own eye is a good enough reason on its own.
Not every slow response means the diagnosis is wrong. Some uveitis genuinely needs time, a higher dose, or a step up to a stronger medicine, and your doctor may already be planning that. If your inflammation is gradually improving, your doctor has explained the plan, and follow-up is scheduled, that is usually a sign the process is working. A second opinion in that setting can still add reassurance, but it is a choice rather than a warning sign.
The right expert depends on the question. For stubborn or unusual uveitis, a fellowship-trained uveitis specialist or a retina specialist is the usual next stop, and some cases involve an eye-cancer (ocular oncology) team. Because uveitis often connects to the rest of the body, care may also involve a rheumatologist or an infectious-disease doctor. Ask your current eye doctor for a referral, or contact an academic eye center directly if one is within reach.
Getting the Most From a Second-Opinion Visit
A specialist can help fastest when the back-story is complete. Bring the names and dates of every treatment you have tried and how your eye responded to each, any scans or photographs of the retina, prior blood-test and imaging results, and a full list of your medicines and supplements. A short written timeline of when symptoms started and how they have changed is often more useful than memory alone, and it helps avoid repeating tests you have already had.
Depending on your history, a specialist may repeat parts of the workup or add new pieces. When lymphoma is a concern, the gold-standard step is a vitrectomy, in which a sample of the vitreous gel is removed and examined4. Laboratory analysis such as flow cytometry of that sample helps distinguish lymphoma from infection and ordinary inflammation5. Infection testing, updated imaging, and a review of your medicines are common as well. Your specialist will explain which, if any, apply to you.
Use the visit to reach clear answers, not just a new prescription. Ask what the specialist thinks the diagnosis is and how confident they are, what would change their mind, whether any masquerade has been ruled out, and what the plan is if the next treatment does not work either. Settling these questions turns a second opinion into a decision you can act on rather than one more unfinished conversation.
The Cost of Waiting, and a Realistic Outlook
The main risk of a stubborn 'uveitis' is not the inconvenience, it is a diagnosis that quietly slips. Because vitreoretinal lymphoma is often mistaken for ordinary vitritis and treated with steroids, the correct diagnosis can be delayed5. For an infection or a drug cause, weeks of the wrong treatment can let the real problem continue. This is the practical argument for acting on a poor response rather than assuming more of the same medicine will eventually work.
The reassuring side is that a correct label usually points to a treatment that fits. A genuine steroid-resistant inflammatory uveitis may respond to stronger immune-suppressing or biologic medicines chosen and monitored by a specialist. A drug cause often eases once the medicine is changed. An infection has its own targeted treatment. Getting the diagnosis right is what makes the treatment right, which is the whole point of a second look.
Outcomes vary widely by cause, and no page can predict your own. What is fair to say is that most people with uveitis are helped when the underlying cause is correctly identified and treated, and that the earlier a masquerade is found, the more options tend to remain. A second opinion does not guarantee a better outcome, but for a case that is not responding, it is a sensible way to make sure nothing treatable is being missed.
When to Seek Care Quickly and Who to See
Some changes should not wait for a routine appointment. Call your eye doctor the same day, or seek urgent eye care, if you notice any of the following.
- A sudden drop in your vision or a new blank spot.
- New or rapidly increasing floaters, flashing lights, or a shadow or curtain across your sight.
- Severe eye pain, or a very red eye with light sensitivity.
- Any fast worsening of symptoms that were stable before.
Because untreated eye inflammation can threaten sight, new or worsening symptoms should be seen promptly rather than watched at home1. Acting quickly rarely does harm, and it can protect vision when it matters.
For steady, non-urgent concerns, keep your scheduled follow-up and raise your questions there. If your inflammation has not responded as hoped, ask your eye doctor directly about a referral to a uveitis or retina specialist. Keeping every appointment matters, because uveitis and its look-alikes are usually managed over months with repeated checks rather than a single visit.
Common Questions About Steroid-Resistant Uveitis
No. A poor response is far more often explained by the dose, the type of uveitis, or the need for a stronger anti-inflammatory medicine than by cancer. A masquerade like lymphoma is uncommon and mainly considered in older adults with persistent inflammation inside the eye. The point of a second opinion is not to assume the worst, it is to make sure a treatable cause, whatever it is, is not being overlooked.
It is possible, which is why it is worth reviewing. Several drugs are recognized causes of eye inflammation, and the eye usually improves once the responsible medicine is identified and stopped. Bring a full list of everything you take, including recently started cancer treatments and antibiotics, to your visit. Never stop a prescribed medicine on your own; ask the doctor who prescribed it whether it could be involved and what the alternatives are.
There is no single number, because it depends on the type and severity of the inflammation and the form of steroid used. A fair rule of thumb is that if your eye is not clearly improving on an adequate treatment, or if it keeps relapsing, that is a reasonable moment to ask whether the diagnosis has been reconsidered. Your treating doctor is best placed to judge what counts as a fair trial in your case.
A second opinion is a normal part of medicine, and most eye doctors welcome it for a difficult case. You can frame it simply: you would like another specialist to weigh in because the inflammation has not settled. A good clinician would rather have help reaching the right answer than see a treatable cause missed. Asking does not mean firing your doctor, and the two can work together.
For stubborn or unusual uveitis, a fellowship-trained uveitis specialist or a retina specialist is the usual next step, often at an academic eye center. Some cases also involve an eye-cancer team, a rheumatologist, or an infectious-disease doctor, depending on the suspected cause. Ask your current eye doctor for a referral, and mention that the inflammation has not responded to steroids so the right expert is chosen.
More Questions, and What to Ask Your Doctor
Most people never need one. A vitreous biopsy, done as part of a vitrectomy, is considered mainly when a masquerade such as lymphoma is genuinely suspected, and it is the standard way to confirm that diagnosis. Like any eye surgery it carries some risk, which your surgeon would explain in detail beforehand. Whether it applies to you depends on your history and exam, and it is a decision made with your specialist, not something to seek out on your own.
Sometimes, in part. Blood tests and imaging can point toward infections or inflammatory diseases that mimic uveitis, which is why they are often part of the workup. But some masquerades, especially lymphoma, usually need a sample taken from inside the eye to confirm. So a normal blood test is reassuring but does not rule out every look-alike, which is one reason a specialist may recommend further testing.
- What do you think my diagnosis is, and how confident are you in it?
- Have infections and other masquerade conditions been ruled out?
- Could any medicine I take be contributing to the inflammation?
- What would a fair trial of my current treatment look like, and what is the plan if it does not work?
- Would you recommend a uveitis or retina specialist, and can you refer me?
- National Eye Institute (NEI/NIH) (2023). Uveitis.
- PMC (case series) (2023). Uveitis masquerade syndromes: A case series.
- American Academy of Ophthalmology, YO Info (2021). 10 Clinical Pearls for Treating Uveitis.
- American Academy of Ophthalmology, EyeNet Magazine (2020). Primary Vitreoretinal Lymphoma.
- PMC (peer-reviewed review) (2024). Primary vitreoretinal lymphoma: diagnosis, treatment, and prognosis, a review of current knowledge and future directions.
- Indian Journal of Ophthalmology (PMC7690475) (2020). Drug-induced uveitis: A review.